Hana Park

Hana Park

Auto-generated profile, based on publicly available information

Hana Park

Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Cancers
Verified
Journal Article
Open access
PDF file
YCYoung Eun Chon
Young Eun Chon
HPHana Park
Hana Park
HHHye Kyung Hyun
Hye Kyung Hyun
YHYeonjung Ha
Yeonjung Ha
MKMi Na Kim
Mi Na Kim
JPJun Yong Park
Jun Yong Park
The neutrophil-to-lymphocyte ratio (NLR) has recently been reported to predict the prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the survival of patients with HCC undergoing transarterial chemoembolization (TACE), and developed a predictive model. In total, 1697 patients with HCC undergoing TACE as first-line therapy at two university hospitals were enrolled (derivation set n = 921, internal validation set n = 395, external validation set n = 381). The tumor size, tumor number, AFP level, vascular invasion, Child–Pugh score, objective response after TACE, and NLR, selected as predictors of overall survival (OS) via multivariate Cox’s regression model, were incorporated into a 14-point risk prediction model (SNAVCORN score). The time-dependent areas under the receiver-operating characteristic curves for OS at 1, 3, and 5 years predicted by the SNAVCORN score were 0.812, 0.734, and 0.700 in the derivation set. Patients were stratified into three risk groups by SNAVCORN score (low, 0–4; intermediate, 5–9; high, 10–14). Compared with the low-risk group, the intermediate-risk (HR 3.10, p < 0.001) and high-risk (HR 7.37, p < 0.001) groups exhibited significantly greater mortality. The prognostic performance of the SNAVCORN score including NLR in patients with HCC treated with TACE was remarkable, much better than those of the conventional scores. The SNAVCORN score will guide future HCC treatment decisions.

15 November 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
SSSeung Kak Shin
Seung Kak Shin
IJIjin Joo
Ijin Joo
DSDo Seon Song
Do Seon Song
Jeong Won JangJeong Won Jang
Jeong Won Jang
JPJoong-Won Park
Joong-Won Park
Hana Park, Seung Kak Shin, Ijin Joo, Do Seon Song, Jeong Won Jang, and Joong-Won Park. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19163

30 January 2020 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SPSoo-Kyung Park
Soo-Kyung Park
CCChang Hwan Choi
Chang Hwan Choi
JCJaeyoung Chun
Jaeyoung Chun
HLHeeyoung Lee
Heeyoung Lee
EKEun-Sun Kim
Eun-Sun Kim
IDIBD Research Group of the Korean Association for the Study of Intestinal Diseases
IBD Research Group of the Korean Association for the Study of Intestinal Diseases
The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.

18 July 2025 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
JLJI YOUNG LEE
JI YOUNG LEE
SPSungwon Park
Sungwon Park
HLHyo Jeong Lee
Hyo Jeong Lee
SBSuh Eun Bae
Suh Eun Bae
JSJu Hyun Shim
Ju Hyun Shim
Hana Park, Ji Young Lee, Sungwon Park, Hyo Jeong Lee, Suh Eun Bae, Jaeil Kim, Hye-Sook Chang, Jaewon Choe, Hye Won Park, Ju Hyun Shim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250053

25 April 2025 in Gut and Liver
Verified
Journal Article
Open access
PDF file
SBSuh Eun Bae
Suh Eun Bae
KCKee Don Choi
Kee Don Choi
JCJaewon Choe
Jaewon Choe
MLMin Jung Lee
Min Jung Lee
SKSeon-Ok Kim
Seon-Ok Kim
HJHwoon-yong Jung
Hwoon-yong Jung
Suh Eun Bae, Kee Don Choi, Jaewon Choe, Min Jung Lee, Seonok Kim, Ji Young Choi, Hana Park, Jaeil Kim, Hye Won Park, Hye-Sook Chang, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240494

15 September 2026 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
JLJI YOUNG LEE
JI YOUNG LEE
JKJa Eun Koo
Ja Eun Koo
JLJong Soo Lee
Jong Soo Lee
SPSungwon Park
Sungwon Park
JSJu Hyun Shim
Ju Hyun Shim
Hana Park, Ji Young Lee, Ja Eun Koo, Jong Soo Lee, Sungwon Park, Hye Won Park, Hye-Sook Chang, Hong-Kyu Kim, Jaewon Choe, Ju Hyun Shim. Gut and Liver 2026;20:880-92. https://doi.org/10.5009/gnl260186